Clin2
NCT07001787Possibly a fitNot yet recruiting

Safety study of HS-10510 in healthy volunteers

Dyslipidemia

Part of Hormones & metabolism clinical trials.

This trial tests a new drug called HS-10510 in healthy people to see if it is safe and how the body handles it. It is for healthy adults who meet specific weight and cholesterol levels.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
88 people
Ages
18 years to 55 years
Study type
Interventional

Who can take part

  • You are between 18 and 55 years old and in good health
  • You have a body mass index (BMI) between 19 and 35, depending on the part of the study
  • You have never taken a PCSK9 inhibitor like inclisiran
  • You are not a heavy smoker and agree not to smoke during the study
  • You are willing to avoid alcohol, caffeine, grapefruit, and certain other foods
  • You must use effective contraception and not donate sperm or eggs for a period after the study

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07777003Not yet recruiting· Phase 1
Study of a new drug for mild high cholesterol

This trial tests a new drug called HS-10582 in healthy people and those with slightly high LDL cholesterol (a type of cholesterol). The goal is to see if it is safe and how well your body handles it.

NCT06669429Recruiting· Phase 1
Safety study of RS-C1001 in healthy Chinese adults

This study tests a new medication called RS-C1001 in healthy Chinese volunteers to see if it's safe and how the body processes it. The drug may help lower cholesterol, but the main goal here is to check for side effects.

Beijing
NCT07162441Recruiting· Phase 1
Drug interaction study in healthy volunteers

This trial tests two experimental drugs in healthy adults to see how they interact with each other and to check their safety. It involves taking the drugs in a specific order over multiple days.

Seoul, Gwanak-gu
NCT07040046Recruiting· Phase 1
Study of HS-10542 in healthy volunteers

This trial tests an investigational drug, HS-10542, in healthy adults to see how it is processed by the body and to check for side effects. You must be willing to receive two vaccines before the study starts.

Qingdao, Shandong
NCT06504043Enrolling by invitation· Phase 1
Safety study of HST101 in healthy Chinese adults with high cholesterol

This study tests a new drug, HST101, to see if it is safe for healthy Chinese people with high cholesterol. It is an early-phase trial, so it focuses on safety first.

Chengdu, Sichuan
NCT07229937Recruiting· Phase 2
Testing an experimental drug for high cholesterol

This study tests an experimental drug called HRS-1301 to see if it safely lowers LDL ("bad") cholesterol in people with high cholesterol. It is for adults who either already have artery disease or are at higher risk for it.

Harbin, Heilongjiang

Hear when a new Dyslipidemia trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.